Mitigating effects of sublethal and lethal whole-body gamma irradiation in a mouse model with soluble melanin

J Radiol Prot. 2022 Jan 17;42(1). doi: 10.1088/1361-6498/ac3dcf.

Abstract

The field of radiation countermeasures is growing, however, currently there are no effective and non-toxic compounds which could be administered orally to the individuals post exposure to high doses of ionising radiation. The pigment melanin is ubiquitous through all kingdoms of life and provides selective advantage under radiation stress through its role as a chemical and physical shield, and its capacity to respond and react to exposures. Soluble allomelanin was administered to mice following whole-body exposure to lethal or sublethal doses of gamma radiation to determine its capacity to mitigate the effects of acute radiation syndrome, and its utility as a radiation countermeasure. Allomelanin has shown a trend to improve survival post an 8 Gy sublethal radiation exposure when administered up to 48 h post-irradiation. Furthermore, it improved median and overall survival to a 10 Gy lethal radiation exposure, specifically when administered at 24 h post-irradiation. Histological analysis on the jejunum region of the small intestine of this treatment group indicated that alterations of the mucosal and submucosal architecture, and disruption of the lymphatic system associated with lethal radiation exposure were mitigated when allomelanin was administered at 24 h post-irradiation. Based on this work soluble allomelanin derived from a fungal source could serve as an easily sourced, cost-effective, and viable countermeasure to accidental radiation exposure and merits further investigation.

Keywords: acute radiation syndrome; allomelanin; countermeasure; fungus; pigment; radiation.

MeSH terms

  • Acute Radiation Syndrome*
  • Animals
  • Gamma Rays
  • Melanins*
  • Mice
  • Radiation Dosage
  • Whole-Body Irradiation / adverse effects

Substances

  • Melanins